Filing Details
- Accession Number:
- 0001140361-13-036922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-24 18:24:05
- Reporting Period:
- 2013-09-20
- Filing Date:
- 2013-09-24
- Accepted Time:
- 2013-09-24 18:24:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
315545 | Provectus Pharmaceuticals Inc | PVCT | Pharmaceutical Preparations (2834) | 900031917 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1550814 | Jan Koe | 1204 E. Central Road Suite 100 Arlington Heights IL 60005 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-20 | 100,000 | $0.00 | 586,300 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2013-09-20 | 150,000 | $0.00 | 150,000 | $1.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
150,000 | 2013-09-20 | 2018-09-20 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 150,000 | Indirect | By Vekoe Partners LLC |
Footnotes
- The reported securities were purchased together, such that the purchase price for each share of common stock together with a warrant to purchase one and one-half shares of common stock is $0.75.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.